Ipsen

Ipsen Pre-Tax Margin

The Pre-Tax Profit Margin of Ipsen (IPN.PA) as of Nov 7, 2026 is 15.73 %. In the previous year, Pre-Tax Profit Margin was 12.09 % — a change of 30.09% (higher).

Pre-Tax Margin

15.73 %

YoY

30.09%

Last updated:

Pre-Tax Profit Margin of Ipsen is 2025 15.73 % . Pre-Tax Profit Margin of Ipsen was 2024 12.09 % . It decreases by 30.09% higher compared to the previous year.

The Ipsen Pre-Tax Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Pre-Tax Margin
Date
Pre-Tax Margin
Jan 1, 2018
21.09 EUR
Jan 1, 2019
-1.29 EUR
Jan 1, 2020
19.77 EUR
Jan 1, 2021
28.72 EUR
Jan 1, 2022
22.32 EUR
Jan 1, 2023
22.87 EUR
Jan 1, 2024
12.09 EUR
Jan 1, 2025
15.73 EUR
The Ipsen Pre-Tax Margin history
YEARPre-Tax MarginYoY
15.73 %+30.09%
12.09 %-47.13%
22.87 %+2.47%
22.32 %-22.31%
28.72 %+45.28%
19.77 %-1,629.90%
-1.29 %-106.13%
21.09 %+14.04%
18.49 %+3.03%
17.95 %+13.63%
15.79 %+1.03%
15.63 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ipsen Stock analysis

What does Ipsen do? Ipsen SA is a French biopharmaceutical company specialized in the development of drugs for the treatment of cancer, neurological disorders, and endocrine disorders. It was founded in 1929 by a pharmacist named Henri Beaufour and is headquartered in Paris. The history of Ipsen began with the production of extraction products from snake venom for the manufacturing of serum against tetanus and diphtheria. In the 1960s, the company started to focus on the production of hormones and peptides, with a focus on endocrine disorders. In the 1990s, Ipsen expanded its product portfolio to include oncology and neurological disorders. Ipsen's business model focuses on research and development of new drugs, as well as marketing of already established drugs in selected markets worldwide. The company employs around 5,700 employees and operates in more than 115 countries. Ipsen has two main business segments: specialty drugs and consumer healthcare. The specialty drugs segment focuses on the development and marketing of innovative therapies in the areas of oncology, endocrinology, and neuroscience. Ipsen's most well-known products include Somatuline, a drug for the treatment of acromegaly, and Decapeptyl, a drug for the treatment of prostate cancer and endometriosis. In the consumer healthcare segment, Ipsen is mainly specialized in the production of drugs for the treatment of gastrointestinal disorders and cold and flu symptoms. Some well-known brands include Smecta, a drug for diarrhea, and Nurofen, a pain reliever. Ipsen also has a strong presence in the field of aesthetic medicine, where the company operates a subsidiary called Ipsen Aesthetic. This subsidiary develops and markets products for the treatment of wrinkles and other signs of aging on the skin. Well-known brands of Ipsen Aesthetic include Dysport, a botulinum toxin product for the treatment of wrinkles, and the filler Restylane. Overall, Ipsen has established itself as a leading biopharmaceutical company focused on the development and marketing of products in specialized therapy areas. The company has a strong pipeline of new products in development and remains an important player in the pharmaceutical industry due to its strong scientific expertise and global presence. Ipsen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ipsen stock

Pre-Tax Profit Margin of Ipsen is 15.73 % in 2025.

Pre-Tax Profit Margin of Ipsen changed from 12.09 % to 15.73 %, representing a 30.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Pre-Tax Profit Margin Ipsen since 2006 – with annual values, charts, and detailed analysis.

Pre-tax margin measures the percentage of revenue remaining after all expenses except income taxes. It isolates operational and financial performance from tax effects.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Pre-Tax Profit Margin's Ipsen with sector peers and the industry average to assess whether it is attractive.

To evaluate Pre-Tax Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Pre-Tax Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Ipsen

All Key Metrics — Ipsen